Viridian Therapeutics, Inc.\DE (VRDN) Asset Utilization Ratio: 2014-2025

Historic Asset Utilization Ratio for Viridian Therapeutics, Inc.\DE (VRDN) over the last 11 years, with Sep 2025 value amounting to 0.12.

  • Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio rose 27344.94% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year increase of 27344.94%. This contributed to the annual value of 0.00 for FY2024, which is 27.80% down from last year.
  • According to the latest figures from Q3 2025, Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio is 0.12, which was up 24,787.83% from 0.00 recorded in Q2 2025.
  • Viridian Therapeutics, Inc.\DE's 5-year Asset Utilization Ratio high stood at 0.12 for Q3 2025, and its period low was 0.00 during Q4 2024.
  • Over the past 3 years, Viridian Therapeutics, Inc.\DE's median Asset Utilization Ratio value was 0.00 (recorded in 2024), while the average stood at 0.01.
  • In the last 5 years, Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio crashed by 92.53% in 2021 and then spiked by 27,344.94% in 2025.
  • Quarterly analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Asset Utilization Ratio stood at 0.01 in 2021, then plummeted by 70.98% to 0.00 in 2022, then slumped by 81.06% to 0.00 in 2023, then slumped by 47.97% to 0.00 in 2024, then skyrocketed by 27,344.94% to 0.12 in 2025.
  • Its Asset Utilization Ratio was 0.12 in Q3 2025, compared to 0.00 in Q2 2025 and 0.00 in Q1 2025.